{"id":61228,"date":"2020-06-12T11:30:59","date_gmt":"2020-06-12T09:30:59","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=61228"},"modified":"2020-06-09T15:51:51","modified_gmt":"2020-06-09T13:51:51","slug":"advancecor-financing-round","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/61228\/advancecor-financing-round\/","title":{"rendered":"AdvanceCor raises 3.9 million euros"},"content":{"rendered":"
\n

AdvanceCor has completed a financing round with MIG AG, Occident, First Capital Partner, Bayern Kapital, and KfW Bank, initially totaling nearly \u20ac3.9 million. A second closing is scheduled for the end of 2020, making this financing round open to new investors. The Martinsried-based biotech company develops personalized therapies for cardiovascular diseases. Its main project, Revacept, is a specific inhibitor of pathological thrombosis without affecting the body's own hemostasis.<\/strong><\/p>\n\n\n\n

The lead investor in the recently completed financing round of AdvanceCor<\/a> is the MIG AG<\/a> from Munich. The co-investors in the consortium include Bavaria Capital<\/a> and KfW Bank. External investors are invited to participate in a second closing of the round at the end of the year, with a total of up to EUR 2 million.<\/p>\n\n\n\n

Both the investors and the founders of the company are pleased with the financing achieved so far. Prof. Dr. G\u00f6tz M\u00fcnch<\/strong>, CEO and founder of AdvanceCor, says: <\/p>\n\n\n\n

"We are pleased that we were able to secure such financing with our reliable investors, even in these difficult times of the coronavirus pandemic. This financing will enable us to evaluate the data from two clinical trials. The goal is to sell or further jointly develop the lead project with a pharmaceutical partner for our promising substance Revacept."<\/p><\/blockquote>\n\n\n\n

Two successfully conducted patient studies<\/h2>\n\n\n\n

With the current financing, AdvanceCor<\/a> Complete the partnership for the Phase II Revacept project. Two patient studies have already been successfully completed. A further patient study with Revacept in patients with coronary artery disease undergoing catheter intervention\/stenting has also been completed, in collaboration with the German Center for Cardiovascular Research. The data are currently being evaluated for efficacy and safety. <\/p>\n\n\n\n

The results from these two clinical trials may demonstrate for the first time that additional anti-ischemic protection (Editor's note: anti-ischemic means \u201cacting against reduced blood flow\u201d<\/em>) can be performed safely even in surgical or catheter-interventional interventions without additional bleeding complications. <\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

AdvanceCor has completed a financing round with MIG AG, Occident, First Capital Partner, Bayern Kapital, and KfW Bank, initially totaling nearly \u20ac3.9 million. A second closing is scheduled for the end of 2020, making this financing round open to new investors. The Martinsried-based biotech company develops personalized therapies...<\/p>","protected":false},"author":24,"featured_media":36353,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[3162,52],"acf":[],"yoast_head":"\nFrisches Kapital f\u00fcr Biotech-Unternehmen AdvanceCor \u2013 Munich Startup<\/title>\n<meta name=\"description\" content=\"Frisches Kapital f\u00fcr AdvanceCor: das Biotech-Unternehmen aus Martinsried kann bei einer Finanzierungsrunde rund 3,9 Millionen Euro einsammeln.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/61228\/advancecor-financing-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frisches Kapital f\u00fcr Biotech-Unternehmen AdvanceCor \u2013 Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Frisches Kapital f\u00fcr AdvanceCor: das Biotech-Unternehmen aus Martinsried kann bei einer Finanzierungsrunde rund 3,9 Millionen Euro einsammeln.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/61228\/advancecor-financing-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-12T09:30:59+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/\",\"url\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/\",\"name\":\"Frisches Kapital f\u00fcr Biotech-Unternehmen AdvanceCor \u2013 Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"datePublished\":\"2020-06-12T09:30:59+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Frisches Kapital f\u00fcr AdvanceCor: das Biotech-Unternehmen aus Martinsried kann bei einer Finanzierungsrunde rund 3,9 Millionen Euro einsammeln.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\",\"width\":1280,\"height\":853,\"caption\":\"AdvanceCor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AdvanceCor sammelt 3,9 Millionen Euro ein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fresh capital for biotech company AdvanceCor \u2013 Munich Startup","description":"Fresh capital for AdvanceCor: the biotech company from Martinsried was able to raise around 3.9 million euros in a financing round.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/61228\/advancecor-financing-round\/","og_locale":"en_US","og_type":"article","og_title":"Frisches Kapital f\u00fcr Biotech-Unternehmen AdvanceCor \u2013 Munich Startup","og_description":"Frisches Kapital f\u00fcr AdvanceCor: das Biotech-Unternehmen aus Martinsried kann bei einer Finanzierungsrunde rund 3,9 Millionen Euro einsammeln.","og_url":"https:\/\/cms.munich-startup.net\/en\/61228\/advancecor-financing-round\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2020-06-12T09:30:59+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/","url":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/","name":"Fresh capital for biotech company AdvanceCor \u2013 Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","datePublished":"2020-06-12T09:30:59+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"Fresh capital for AdvanceCor: the biotech company from Martinsried was able to raise around 3.9 million euros in a financing round.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","width":1280,"height":853,"caption":"AdvanceCor"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/61228\/advancecor-finanzierungsrunde\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"AdvanceCor sammelt 3,9 Millionen Euro ein"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":1280,"height":853,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/05\/ecg-2270728_1280.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1634195062:38","_edit_last":"22","_yoast_wpseo_focuskw":"AdvanceCor","_yoast_wpseo_metadesc":"Frisches Kapital f\u00fcr AdvanceCor: das Biotech-Unternehmen aus Martinsried kann bei einer Finanzierungsrunde rund 3,9 Millionen Euro einsammeln.","_yoast_wpseo_linkdex":"74","_thumbnail_id":"36353","wbounce_status":"default","_yoast_wpseo_primary_category":"","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"Frisches Kapital f\u00fcr Biotech-Unternehmen AdvanceCor \u2013 Munich Startup","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61228"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=61228"}],"version-history":[{"count":5,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61228\/revisions"}],"predecessor-version":[{"id":61267,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61228\/revisions\/61267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/36353"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=61228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=61228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=61228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}